Finance

Beta
Lists
APS:TSE
Aptose Biosciences Inc
CAD 2,20
0,00%
(0,00) 1D
5 Jun., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for APS...
Open
CAD 2,20
High
CAD 2,20
Low
CAD 2,20
Mkt. cap
36,19 m
Avg. vol.
2,92 k
Volume
100,00
52-wk high
CAD 2,59
52-wk low
CAD 1,02
Beta
0,11
Shares outstanding
2,55 m
No. of employees
14
Open
CAD 2,20
High
CAD 2,20
Low
CAD 2,20
Mkt. cap
36,19 m
Avg. vol.
2,92 k
Volume
100,00
52-wk high
CAD 2,59
52-wk low
CAD 1,02
Beta
0,11
Shares outstanding
2,55 m
No. of employees
14
News stories
From sources across the web
About Aptose Biosciences Inc
CEO-
Employees14
Founded1986
HeadquartersToronto, Ontario, Kanada
Sector-
Websiteaptose.com
Last report
13 Aug. 2025
Fiscal period
Q2 2025
EPS / Est. (USD)
-USD 2,76 / -USD 2,74
-0,73%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,30 m
2,20 m
3,47 m
3,62 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,62 m
2,71 m
3,95 m
3,56 m
Operating expense
6,92 m
4,91 m
7,43 m
7,18 m
Total operating expenses
6,92 m
4,91 m
7,43 m
7,18 m
Operating income
-6,92 m
-4,91 m
-7,43 m
-7,18 m
Other non operating income
-
-
-
-19,00 k
EBT including unusual items
-7,04 m
-5,12 m
-7,76 m
-7,63 m
EBT excluding unusual items
-7,04 m
-5,12 m
-7,76 m
-7,63 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,04 m
-5,12 m
-7,76 m
-7,63 m
Net profit margin
-
-
-
-
Earnings per share
-2,76
-
-
-
Interest and investment income
-
-
105,00 k
-
Interest expense
-110,00 k
-212,00 k
-437,00 k
-433,00 k
Net interest expenses
-110,00 k
-212,00 k
-332,00 k
-433,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,92 m
-4,90 m
-7,42 m
-7,18 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer